| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.05. | Protara Therapeutics Inc reports results for the quarter ended in January - Earnings Summary | 1 | Reuters | ||
| 02.05. | Protara Therapeutics GAAP EPS of -$0.97 | 2 | Seeking Alpha | ||
| 02.05. | Protara Therapeutics, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 02.05. | Protara Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.04. | Lexicon Pharmaceuticals, Bio-Path Holdings, Protara Therapeutics among healthcare movers | 6 | Seeking Alpha | ||
| 05.04. | Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity | 3 | Benzinga.com | ||
| 05.04. | Protara Therapeutics jumps 23% on $45M oversubscribed private financing | 2 | Seeking Alpha | ||
| 05.04. | Protara Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.04. | Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC | 90 | GlobeNewswire (Europe) | TARA-002 demonstrated a complete response rate of 43% at three months in BCG-Unresponsive/Experienced patients in ongoing NMIBC programTARA-002 demonstrated a complete response rate of 63% at three... ► Artikel lesen | |
| 05.04. | Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition | 204 | GlobeNewswire (Europe) | New development pathway significantly expands addressable patient population for IV Choline ChlorideIV Choline Chloride has the potential to become the first FDA-approved IV formulation of choline... ► Artikel lesen | |
| 05.04. | Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing | 3 | GlobeNewswire (USA) | ||
| 14.03. | Protara Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 13.03. | Protara Therapeutics, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| 13.03. | Protara Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.03. | Protara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update | 66 | GlobeNewswire (Europe) | Preliminary results from ADVANCED-1EXP trial evaluating TARA-002 in NMIBC patients with CIS on track for 1H 2024Preliminary data from ADVANCED-2 trial evaluating TARA-002 in NMIBC patients with BCG-unresponsive... ► Artikel lesen | |
| 31.01. | Protara Therapeutics to Participate in Upcoming Investor Conferences | 1 | GlobeNewswire (USA) | ||
| 30.11.23 | Protara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology | 1 | GlobeNewswire (USA) |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 256 |
| BAYER | 213 |
| TUI | 198 |
| NEL | 190 |
| SIEMENS ENERGY | 181 |
| RHEINMETALL | 160 |
| NOVAVAX | 153 |
| MERCEDES-BENZ | 150 |
| PLUG POWER | 141 |
| PALANTIR TECHNOLOGIES | 136 |
| NVIDIA | 135 |
| RWE | 135 |
| TESLA | 124 |
| BYD | 114 |
| DEUTSCHE BANK | 105 |
| ALLIANZ | 102 |
| BASF | 100 |
| COMMERZBANK | 88 |
| DEUTSCHE LUFTHANSA | 85 |
| VOLKSWAGEN | 81 |
| INFINEON | 78 |
| JINKOSOLAR | 73 |
| HELLOFRESH | 72 |
| NORDEX | 69 |
| PAYPAL | 68 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
